About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 389579, 6 pages
http://dx.doi.org/10.1155/2013/389579
Research Article

Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma

1Hematology Department, University Hospital of Heraklion, P.O. Box 1352, Stavrakia, 71110 Heraklion, Greece
2Hematology Laboratory, University Hospital of Heraklion, Stavrakia, 71110 Heraklion, Greece
33rd Department of Internal Medicine, Medical School of Athens, Sotiria Hospital, 11527 Athens, Greece
4Pathology Department, University Hospital of Heraklion, Stavrakia, 71110 Heraklion, Greece
5Hematology Department, Venizelion Hospital of Heraklion, 71409 Heraklion, Greece

Received 6 April 2013; Revised 9 June 2013; Accepted 23 June 2013

Academic Editor: Jerome Moreaux

Copyright © 2013 Michael G. Alexandrakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Michael G. Alexandrakis, Parascevi Roussou, Constantina A. Pappa, et al., “Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma,” BioMed Research International, vol. 2013, Article ID 389579, 6 pages, 2013. doi:10.1155/2013/389579